We have correlated the onset age of refractory Epilepsy with efficacy of Lamotrigine used as add-on for a population of 389 patients treated for at least 2 years. Age groups were defined as ranging for 0 to 3 years, 4 to 12 years, 13 to 20 years and ultimately 21 years and beyond. The result obtained show similar responder frequency in the first two age groups for the Cryptogenetic and Symptomatic Generalized Epilepsy, and in the first three age groups for the Partial Epilepsy.

Studio triveneto sulla lamotrigina: Correlazione tra efficacia del farmaco e l'età di esordio dell'epilessia nelle varie forme sindromiche

DE MARCO, PASQUALE;BERGONZI, Paolo;COSTA, PIETRO;CRISTOFORI, Guido;GIGLI, Gian Luigi;LUCCI, Bruno;MARINIG, Roberto;PANICO, ANNA CLARA;PAULETTO, GIADA;PRIVATO, Fiorenza;SERENA, MARINA;TOLDO, MASSIMILIANO;
2002-01-01

Abstract

We have correlated the onset age of refractory Epilepsy with efficacy of Lamotrigine used as add-on for a population of 389 patients treated for at least 2 years. Age groups were defined as ranging for 0 to 3 years, 4 to 12 years, 13 to 20 years and ultimately 21 years and beyond. The result obtained show similar responder frequency in the first two age groups for the Cryptogenetic and Symptomatic Generalized Epilepsy, and in the first three age groups for the Partial Epilepsy.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11390/1113987
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact